Tag: Kevzara
Regeneron drug for rheumatoid arthritis approved in Europe
The European Commission approved the use of Kevzara under certain conditions to treat adults with moderately to severely active rheumatoid arthritis.
FDA approves Regeneron drug Kevzara for rheumatoid arthritis
The new human antibody drug will be used to treat a chronic inflammatory disease that affects about 1.3 million Americans.